Medical technology company Stryker (NYSE:SYK) reported Q2 CY2025 results topping the market’s revenue expectations, with ...

Stryker Corp (SYK) reports robust sales and EPS growth, raises full-year guidance despite ongoing supply chain issues.

Revenue (GAAP) increased 11.1% to $6.0 billion, above analyst expectations. Adjusted earnings per share rose 11.4% to $3.13, exceeding consensus estimates. Full-year 2025 guidance was raised for both ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $429.5, a high estimate of $455.00, and a low estimate of $400.00. Marking an increase of 3.18%, the ...

PORTAGE, Mich. (AP) — PORTAGE, Mich. (AP) — Stryker Corp. (SYK) on Thursday reported second-quarter net income of $884 million. The Portage, Michigan-based company said it had profit of $2.29 per ...

Stryker raised its annual profit forecast and beat quarterly profit estimates on Thursday, banking on strong demand for its medical and surgical devices.

Medical technology company Stryker (NYSE:SYK) will be reporting results this Thursday after market close. Here’s what you ...

Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs ...

Stryker will increase its full-year guidance after a Street-beating second quarter that saw strong demand for products and continued business momentum.

Despite the strong performance and raised full-year guidance, Stryker’s stock declined significantly in trading following the announcement. The company’s MedSurg and Neurotechnology segment showed ...

Inari Medical — now part of Stryker (NYSE: SYK) + — today announced the launch of its next-generation InThrill thrombectomy system. The company describes InThrill as the first and only purpose-built ...

Stryker (SYK) just dropped its Q2 2025 earnings, and spoiler alert: they smashed expectations with an EPS of $3.13 (beating forecasts by 1.95%) and revenue hitting $6.02 billion. Organic sales spiked ...